News from emd serono, inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Jul 29, 2014, 02:30 ET

EMD Serono Initiates Phase II Study of Anti-PD-L1 Antibody MSB0010718C in Metastatic Merkel Cell Carcinoma

  - First patient begins treatment in an international Phase II study investigating the efficacy and safety of MSB0010718C in patients...

Jul 01, 2014, 09:00 ET

EMD Serono Commits EUR 2 million to the Grant for Fertility Innovation (GFI) for 2014 /15

 EMD Serono, Inc., a subsidiary of Merck KGaA, Darmstadt, Germany, today announced its strong support of the Grant for Fertility Innovation...

Jun 24, 2014, 07:30 ET
EMD Serono (PRNewsFoto/EMD Serono)

EMD Serono and Mersana to Develop Next-Generation Antibody-Drug Conjugates

EMD Serono, Inc., a subsidiary of Merck KGaA, Darmstadt, Germany, and Mersana Therapeutics, Inc., Cambridge, Mass., U.S., announced today an...

Jun 11, 2014, 09:00 ET

EMD Serono Launches Compassionate Corps Program to Reduce Cost of Fertility Treatment for Eligible Military Veterans and their Spouses

 EMD Serono, Inc., a subsidiary of Merck KGaA, Darmstadt, Germany announced today its commitment to U.S. military veterans and their spouses...

May 29, 2014, 02:30 ET

EMD Serono to Release New Pipeline Data at ASCO 2014 from Early-Stage Investigational Compounds in Difficult-to-Treat Cancers

ASCO abstract #: Anti-PD-L1: 3064; c-Met: 2521, TPS4151, TPS8121; tecemotide: TPS3658, TPS7608; TH-302: 8534, 2029; further pipeline: 3551,...

May 28, 2014, 09:00 ET
EMD Serono logo.  (PRNewsFoto/EMD Serono, Inc.)

EMD Serono Data at CMSC & ACTRIMS Annual Meeting Reinforces Proven Efficacy of Rebif® (interferon beta-1a) and Demonstrates Continued Commitment to Patients with Relapsing MS

 EMD Serono, Inc., a subsidiary of Merck KGaA, Darmstadt, Germany, announced today that Rebif®  (interferon beta-1a) data will be...

Apr 25, 2014, 09:00 ET
EMD Serono logo.  (PRNewsFoto/EMD Serono, Inc.)

EMD Serono Presents New Data on Rebif® (interferon beta-1a) and Advancing MS Pipeline at AAN Annual Meeting

EMD Serono, Inc., a subsidiary of Merck KGaA, Darmstadt, Germany, announced today that new data from the company's multiple sclerosis (MS)...

Apr 07, 2014, 02:20 ET

EMD Serono Announces Initiation of Phase III START2 Study with Tecemotide in Stage III Non-Small Cell Lung Cancer

   - First patient dosed in tecemotide Phase III trial; study recruiting across 250 sites in over 20 countries   -...

Apr 01, 2014, 08:00 ET
EMD logo.  (PRNewsFoto/EMD Serono, Inc.)

EMD Serono, Inc. Launches 10th Edition of The EMD Serono Specialty Digest™ at Annual Meeting of The Academy of Managed Care Pharmacy

 EMD Serono, Inc., a subsidiary of Merck KGaA, Darmstadt, Germany, today announced the launch of the 10th edition of the EMD Serono...

Apr 01, 2014, 07:00 ET
EMD Serono logo.  (PRNewsFoto/EMD Serono, Inc.)

EMD Serono Enters into Research Agreement with Pfizer and Broad Institute

EMD Serono, a subsidiary of Merck KGaA, Darmstadt, Germany, today announced they have signed a research agreement with Pfizer Inc. and...

Dec 17, 2013, 09:00 ET
EMD logo.  (PRNewsFoto/EMD Serono, Inc.)

EMD Serono, Inc. and the National MS Society Announce Recipients of Funding for Multiple Sclerosis Research

 EMD Serono, Inc., a subsidiary of Merck KGaA, Darmstadt, Germany, and the National Multiple Sclerosis Society through Fast Forward...

Dec 16, 2013, 08:30 ET
EMD Serono logo.  (PRNewsFoto/EMD Serono, Inc.)

EMD Serono's Redesigned Fertility Pen Available for Distribution in US

 EMD Serono, Inc., a subsidiary of Merck KGaA, Darmstadt, Germany, announced today that Gonal-f® RFF Redi-ject™, a disposable...

Oct 05, 2013, 08:00 ET
EMD Serono logo.  (PRNewsFoto/EMD Serono, Inc.)

EMD Serono Makes First Awards as Part of the Company's 1 Million Euro Grant for Multiple Sclerosis Innovation

 EMD Serono, Inc., a subsidiary of Merck KGaA, Darmstadt, Germany, announced today on the occasion of the 29th European Committee...

Oct 01, 2013, 09:00 ET
EMD logo.  (PRNewsFoto/EMD Serono, Inc.)

EMD Serono Exclusive Supporter of Newly Launched Multiple Sclerosis Resource Centre

 EMD Serono, Inc., a subsidiary of Merck KGaA, Darmstadt, Germany, is the founding supporter of the newly launched...

May 28, 2013, 09:00 ET
Jan 03, 2013, 10:00 ET
Pfizer logo.  (PRNewsFoto/EMD Serono)

EMD Serono and Pfizer Announce FDA Approval of Rebif® Rebidose® (interferon beta-1a)

EMD Serono, Inc., a subsidiary of Merck KGaA, Darmstadt, Germany, and Pfizer Inc. announced today that the U.S. Food and Drug...

Dec 20, 2012, 08:00 ET
EMD logo.  (PRNewsFoto/EMD Serono, Inc.)

EMD Serono, Inc. and Fast Forward, LLC Announce Recipients of Funding for Multiple Sclerosis Research

 EMD Serono, Inc., a subsidiary of Merck KGaA, Darmstadt, Germany, and Fast Forward LLC, a wholly-owned subsidiary of the National Multiple...

Oct 11, 2012, 09:00 ET
EMD Serono Logo 1.  (PRNewsFoto/EMD Serono, Inc.)

EMD Serono Launches One Million Euro Research Grant for Multiple Sclerosis Innovation

 EMD Serono, Inc., a subsidiary of Merck KGaA, Darmstadt, Germany, announced today during the European Committee for Treatment and Research in...

Sep 18, 2012, 09:30 ET
EMD Serono Logo 1.  (PRNewsFoto/EMD Serono, Inc.)

EMD Serono Expands the Grant for Fertility Innovation (GFI) Program to Include U.S. Investigators

EMD Serono, Inc., a subsidiary of Merck KGaA, Darmstadt, Germany, announced today that the company has expanded its global program named Grant...

Jan 23, 2012, 08:00 ET

MS LifeLines® Earns J.D. Power and Associates Call Center Certification for Customer Service Excellence in Providing Support Services to the MS Community

EMD Serono, Inc., a subsidiary of Merck KGaA, Darmstadt, Germany, and Pfizer Inc. announced today that the MS LifeLines® call center...